Relmada Therapeutics, Inc. · NASDAQ:RLMD

Relmada Therapeutics, Inc. shareholders

As of Sep 30, 2026, 131 institutions reported holding Relmada Therapeutics, Inc., 97.8% of its shares. Largest: Janus Henderson, BlackRock and Venrock Adviser, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Relmada Therapeutics, Inc.ChangeFiled
Janus Henderson11.2M10.5%first reportNov 16, 2026
BlackRock7.58M7.1%+150KNov 13, 2026
Venrock Adviser, LLC7.45M7.0%+601KNov 16, 2026
Spruce Street Capital LP6.91M6.5%+521KNov 13, 2026
Vanguard6.27M5.9%+131KNov 13, 2026
Jones Hill Capital LP5.24M4.9%+1.58MNov 13, 2026
Adage Capital Partners Gp, L.L.C.4.76M4.5%no changeNov 16, 2026
Ameriprise3.72M3.5%+1.78MNov 16, 2026
Sio Capital Management, LLC3.63M3.4%+2.63MNov 16, 2026
Squadron Capital Management LLC3.5M3.3%−3.85MNov 16, 2026

Relmada Therapeutics, Inc. insider trades